increas
bodi
evid
suggest
transmiss
respiratori
virus
occur
inhal
virusladen
particl
studi
describ
use
aerosol
sampl
system
monitor
preval
airborn
virus
hospit
set
use
skc
aircheck
touch
pump
nation
institut
occup
safeti
health
niosh
bioaerosol
sampler
skc
filter
cassett
blank
aerosol
sampl
collect
hospit
ward
singapor
follow
dnarna
extract
realtim
rtpcrpcr
use
detect
influenza
b
virus
coronavirus
enterovirus
adenovirus
airborn
viru
detect
nine
sampl
among
nine
posit
sampl
eight
pcrposit
adenoviru
one
influenza
viru
data
suggest
bioaerosol
sampl
could
valuabl
monitor
airborn
respiratori
virus
clinic
environ
better
understand
risk
infect
hospit
visit
despit
effort
reduc
incid
nosocomi
infect
measur
practic
good
hand
hygien
use
person
protect
equip
hospitalacquir
infect
still
frequent
two
largest
hospit
singapor
report
averag
one
seven
hospit
patient
acquir
nosocomi
infect
immunocompromis
children
greatest
risk
littl
known
regard
transmiss
respiratori
virus
clinic
environ
theoret
influenza
respiratori
virus
transmit
contact
contagi
person
contamin
fomit
howev
increas
bodi
evid
support
concept
transmiss
inhal
virusladen
particl
specif
airborn
virusladen
particl
thought
play
signific
role
respiratori
viru
transmiss
remain
air
prolong
period
time
inhal
deep
lung
aerosol
sampl
collect
gener
pediatr
ward
kk
women
children
hospit
singapor
use
three
nation
institut
occup
safeti
health
niosh
twostag
cyclon
sampler
one
skc
filter
cassett
preload
polytetrafluoroethylen
ptfe
filter
pore
size
design
sampl
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
aerosol
sampl
collect
per
week
seven
week
may
june
niosh
sampler
station
tripod
place
along
corridor
outsid
open
patient
bed
area
one
skc
filter
cassett
attach
mobil
comput
wheel
cow
use
doctor
nurs
ward
round
sampler
connect
touch
sampl
pump
skc
eightyfour
usa
tygon
tube
cm
length
cm
diamet
air
collect
rate
lmin
total
l
air
collect
fourhour
sampl
period
niosh
sampler
separ
collect
particl
three
aerodynam
diamet
filter
cassett
sampl
tube
niosh
sampler
store
process
prior
nucleic
acid
extract
sampl
materi
collect
size
fraction
combin
describ
ptfe
filter
remov
cassett
attach
niosh
sampler
transfer
ml
falcon
tube
vortex
one
ml
bovin
serum
albumin
bsa
fraction
v
molecular
grade
water
ad
falcon
tube
vortex
one
ml
bsa
ad
conic
tube
niosh
sampler
vortex
bsa
solut
pool
cryovial
tube
two
ml
bsa
fraction
v
solut
ad
falcon
tube
niosh
sampler
vor
demonstr
potenti
airborn
respiratori
virus
circul
among
hospit
children
nurs
staff
visitor
argu
bioaerosol
sampl
could
serv
noninvas
lowcost
method
monitor
novel
respiratori
viru
incurs
clinic
set
better
understand
risk
acquir
respiratori
ill
hospit
visit
articl
tex
transfer
cryovial
tube
store
use
styren
filter
skc
cassett
swab
floqswab
soak
bsa
fraction
v
solut
swab
place
falcon
tube
vortex
transfer
cryovial
qiaamp
viral
rna
kit
qiaamp
dna
blood
kit
qiagen
use
extract
rna
dna
respect
sampl
solut
follow
manufactur
protocol
rna
test
influenza
b
coronaviru
enteroviru
use
superscript
iii
onestep
rtpcr
platinum
taq
polymeras
extract
dna
test
adenoviru
realtim
pcr
use
quantinova
probe
pcr
kit
qiagen
tabl
eight
aerosol
sampl
test
posit
adenoviru
one
test
posit
influenza
viru
aerosol
sampl
realtim
rtpcrpcr
cycl
threshold
ct
valu
consid
posit
eight
adenovirusposit
sampl
retriev
niosh
sampler
particl
aerodynam
diamet
particl
aerodynam
diamet
captur
influenza
virusposit
particl
retriev
mobil
skc
filter
cassett
therefor
none
aerosol
sampl
test
posit
influenza
b
viru
enteroviru
coronaviru
attempt
grow
virus
cell
cultur
posit
aerosol
sampl
unsuccess
pilot
studi
provid
molecular
evid
airborn
respiratori
virus
gener
pediatr
ward
singapor
result
illustr
potenti
airborn
respiratori
virus
circul
among
hospit
children
nurs
staff
visitor
addit
detect
respir
virusladen
particl
diamet
thought
play
signific
role
respiratori
viru
transmiss
aerosol
sampl
test
posit
influenza
viru
adenoviru
demonstr
potenti
virus
transmit
via
airborn
rout
howev
unabl
document
viabil
viru
particl
subsequ
risk
infect
addit
sourc
virus
ward
unknown
recruit
human
subject
access
patient
record
despit
previou
success
attempt
use
niosh
twostag
sampler
pcr
analys
collect
detect
aerosol
influenza
viru
sampl
collect
use
niosh
sampler
studi
test
neg
influenza
viru
captur
detect
aerosol
adenoviru
use
niosh
sampler
howev
none
sampl
skc
filter
cassett
test
posit
adenoviru
result
inconsist
previou
studi
success
recov
adenoviru
dna
aerosol
sampl
collect
use
skc
filter
cassett
patient
wait
room
sampl
session
current
studi
collect
l
air
use
one
skc
filter
cassett
compar
collect
l
air
per
two
skc
filter
cassett
previou
studi
addit
skc
filter
cassett
mobil
current
studi
stationari
previou
studi
higher
sampl
volum
collect
previou
studi
well
differ
mobil
locat
sampler
might
explain
differ
posit
sampl
collect
among
studi
addit
bioaerosol
sampl
collect
handl
method
environment
condit
also
influenc
viabil
airborn
virus
downstream
viru
recoveri
exampl
prolong
sampl
period
compromis
stabil
virusladen
aerosol
result
decreas
viral
recoveri
addit
demonstr
surviv
airborn
influenza
viru
depend
ambient
temperatur
rel
humid
rh
ultraviolet
radiat
level
specif
infect
influenza
simul
examin
room
report
highest
rh
moder
rh
lowest
rh
although
record
temperatur
rh
sampl
site
previou
bioaerosol
studi
record
level
rang
rh
three
differ
hospit
singapor
high
rh
level
singapor
could
explain
low
percentag
influenza
virusposit
aerosol
sampl
studi
one
strength
bioaerosol
sampl
method
quick
noninvas
way
monitor
respiratori
virus
without
interrupt
patient
healthcar
profession
also
requir
littl
manpow
collect
sampl
result
analyz
within
hour
howev
one
limit
detect
method
measur
viral
load
aerosol
sampl
make
difficult
compar
result
quantit
aerosol
studi
clinic
set
addit
pilot
studi
design
collect
patient
data
therefor
abl
match
virusposit
aerosol
sampl
individu
patient
present
hospit
ward
time
sampl
summari
conduct
pilot
studi
monitor
aerosol
respiratori
virus
among
inpati
pediatr
ward
singapor
found
molecular
evid
influenza
viru
adenoviru
demonstr
potenti
airborn
transmiss
comprehend
potenti
risk
transmiss
proofofconcept
project
might
expand
futur
specif
studi
patient
known
posit
clinic
infect
eg
nasopharyng
swab
determin
far
away
viabl
virus
detect
patient
bedsid
addit
futur
studi
might
involv
comprehens
demograph
clinic
risk
factor
analys
help
us
better
understand
phenomenon
superspread
lastli
bioaerosol
surveil
might
use
monitor
clinic
popul
incurs
novel
respiratori
virus
especi
sinc
aerosol
sampl
share
clinic
space
often
requir
inform
consent
